88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Kangpu Biopharmaceuticals Received CDE Approval for Phase IIb Clinical Trial of KPG-818 in Moderate to Severe Cutaneous Manifestations of SLE HEFEI, China , April 28, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals, Ltd. announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) ... 2025-04-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW) Six abstracts accepted for presentation includes post hoc analyses and real-world evidence for ZYMFENTRA ® (infliximab-dyyb) Findings reinforce clinical decision-making in long-term ... 2025-04-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi AppTec Q1 2025 Revenue, Profit Resume Double Digit Growth, Revenue Up 21.0% YoY, Adjusted Non-IFRS Net Profit Up 40.0% YoY; Backlog for Continuing Operations Up 47.1% YoY Total Revenue Reached RMB9.65 Billion , Up 21.0% Year-over-Year; among which Revenue from Continuing Operations Reached RMB9.39 Billion , Up 23.1% Year-over-Year Net Profit Attributable to the Owners ... 2025-04-28T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Comac Medical Announces New Leadership Appointments and International Expansion Leadership transition and strategic growth initiatives mark the next phase of Comac Medical's development under EdgeCap Partners. ... 2025-04-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial Hypercholesterolemia SHANGHAI , April 28, 2025 /PRNewswire/ -- YolTech Therapeutics Co.,Ltd, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, ... 2025-04-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
2025 AACR \| Abbisko Therapeutics Presents Late-Breaking Pre-clinical Research Results on ABSK112 (EGFR exon20ins), ABSK131 (PRMT5*MTA), and ABK-KRAS-1 SHANGHAI , April 28, 2025 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. (Abbisko Therapeutics 02256.HK ) today announced that it has presented four late-breaking pre-clinical research posters ... 2025-04-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ImmVira Presented Clinical Results of Oncolytic Product MVR-C5252 Targeting Malignant Glioma via Convection-Enhanced Delivery at 2025 AACR Annual Meeting SUZHOU, China , April 28, 2025 /PRNewswire/ -- From April 25 to April 30, 2025 , U.S. time, ImmVira presented the Phase I clinical results of its oncolytic Herpes Simplex Virus (" oHSV ") ... 2025-04-28T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Nona Biosciences' Partner Pfizer Presents Preclinical Data on TOP1i-Based ADC Targeting MSLN at AACR Annual Meeting 2025 CAMBRIDGE, Mass. , April 28, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I TM ), today announced that ... 2025-04-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
2025 AACR \| Innovent Presents Preclinical Data of Multiple Novel Molecules including Bispecific and Tri-specific Antibodies and Bispecific ADCs SAN FRANCISCO and SUZHOU, China , April 28, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ... 2025-04-28T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ONO PHARMA USA Announces 2025 Golden Ticket CompetitionNow Accepting Applications from Innovative Startups Ono Partnering with LabCentral and MBC BioLabs for Fifth Consecutive Year ... 2025-04-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2025

Suntek Computer Systems Limited.

All rights reserved